Diagnosis
Temporal arteritis
A chronic granulomatous inflammatory systemic vasculitis affecting small-sized, medium-sized, and large-sized arteries, primarily the superficial temporal arteries.
Also known as: Cranial arteritis, Giant cell arteritis, Horton’s arteritis
Etiology
Cause [t61][bty][pya]
Unknown
Environmental/exogenous antigen: parvovirus, parainfluenza virus, varicella-zoster virus, Chlamydia pneumoniae, and Mycoplasma pneumoniae
Genetic association with the HLA-DR4 haplotype and northern Europe
Commonly associated with polymyalgia rheumatica
Pathophysiology [t61]
Activation of immune responses by presenting antigens --> T lymphocytes --> pro-inflammatory cytokines --> activation of macrophages and multinucleated giant cells:
Granulomatous vasculitis in medium- and large-sized arteries
Localisation:
Vertebral arteries, subclavian arteries, temporal/ophthalmic/occipital/ciliary arteries
Clinical manifestation:
Headache
Fever, malaise, depression, anorexia, and weight loss
Visual disturbances: scotoma
Jaw claudication, tongue pain
Musculoskeletal: Polymyalgia rheumatica (myalgia, stiffness)
Abnormal temporal artery biopsy
Upper extremity claudication, Raynaud phenomenon
CNS: Transient ischemic attacks or stroke
Complications [bty][pya]
Permanent blindness
Aortic aneurysm/dissection
Stroke
Tongue necrosis
Glucocorticoid side effect
Cataract formation
Fragility fractures
Infection
Hypertension
Adrenal insufficiency
Diabetes
Osteoporosis
Osteonecrosis
Weight gain
Epidemiology
Incidence per 100.000 [f4t][sfc][bty][t61]
Symptoms & findings
Symptoms
Blindness, Blurred vision, Claudication, Diplopia, Dizziness, Fatigue, Fever, Hallucinations, Headache, Jaw claudication, Malaise, Myalgia, Night sweats, Scotoma, Stiffness, Vertigo, Weight loss
Clinical findings
Anemia, Elevated CRP, Elevated Sedimentation Rate
Anamneses
None listed.
Localized findings
Approach
Clinical diagnosis
Blood tests: complete blood count, erythrocyte sedimentation rate, CRP, transaminases, blood glucose levels, creatinine kinase, aldolase, electrolytes, creatinine, calcium, phosphorus, albumin, alkaline phosphatase, 25-hydroxyvitamin D, and total protein [pya]
Biopsy of the temporal artery
Ultrasonography of the head, neck, and upper extremities
Protein electrophoresis
Urinalysis
CT angiography
PET-CT
GCA Classification Criteria
3 or more of the following parameters:
Age ≥ 50 years
New headache
Tenderness or decreased pulsation of the temporal artery
ESR ≥50 mm/h
A temporal artery biopsy reveals vasculitis, characterized by a predominance of mononuclear cell infiltration, granulomatous inflammation, or multinucleated giant cells
Treatment
Prednisolone 40 to 60 mg/day for 2 to 4 weeks [bty][pya]
If impending danger of blindness --> IV methylprednisolone 1 g/day for 3 days
If clinical remission, decrease the dose to reach 20 mg/day and later 10 mg/day
Aspirin (81 mg) --> prevention of visual loss and stroke
Biologic agents: Tocilizumab (IL-6 inhibitor antagonist)
Management of dietary sugar, salt, and caloric intake
Differential diagnoses
Endocarditis, Microscopic polyangiitis, Optic neuritis, Polyarteritis nodosa, Polymyalgia rheumatica, Septic aortitis, Stroke, Takayasu arteritis, Transient ischemic attack, Wegener's granulomatosis
References
[1] https://emedicine.medscape.com/article/1612591
[2] https://emedicine.medscape.com/article/332483
[3] Ameer MA, Vaqar S, Khazaeni B. Giant Cell Arteritis (Temporal Arteritis) Updated 2024 May 2: https://www.ncbi.nlm.nih.gov/books/NBK459376/
[4] Garvey TD, Koster MJ, Crowson CS, Warrington KJ. Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort. Semin Arthritis Rheum. 2021 Dec;51(6):1193-1199.
[5] Brekke LK, Diamantopoulos AP, Fevang BT, Aβmus J, Esperø E, Gjesdal CG. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study. Arthritis Res Ther. 2017 Dec 15;19(1):278.